24/05/20 -"Separating the wheat from the chaff"
24/05/20 -"Separating the wheat from the chaff"
MedTech, which has historically been a defensive sector, has once again stood its ground even as broader markets have been rattled by the pandemic. But, digging into the details throws up interesting trends: the resilience is underpinned by clear extremes. Hence, leveraging the right opportunities assumes a greater importance and is critical to outperformance. At the upcoming webinar, we will dissect these conflicting trends and share some interesting stock ideas that are best suited to win in a COVID-stricken world.
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
| Corporate broking | NO |
| Trading in corporate shares | NO |
| Analyst ownership | NO |
| Advising of corporate (strategy, marketing, debt, etc) | NO |
| Research paid for by corporate | NO |
| Provision of corporate access paid for by corporate | NO |
| Link between and a banking entity | NO |
| Brokerage activity at AlphaValue | NO |